The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

December 17, 2025

Pharmacists Fight Back Act Reintroduced in the House

The Pharmacists Fight Back Act has been reintroduced in the House by Reps. Jake Auchincloss (D-MA), James Comer (R-KY), and Diana Harshbarger (R-TN). The bill numbers are H.R. 6609 and H.R. 6610. It joins other significant PBM reform bills that are currently pending in Congress, such as the PBM Reform Act (H.R. 4317) and the PBM Price Transparency and Accountability Act (S. 3345), which include the PBM reforms that nearly passed last December in the original Continuing Resolution package. 

The Pharmacists Fight Back Act aims to address pharmacy reimbursement and provide significant penalties for PBM violations. Among other things, it would reform payments in federal health programs — including Medicare, Medicaid, and the Federal Employees Health Benefits Program — by requiring reimbursements that are based on acquisition costs and fair dispensing fees. It would also ban patient steering and allows for patients to choose their pharmacy, and redirects PBM rebates to the patients and plan sponsors to decrease premiums.

[Harshbarger Introduces Bipartisan Pharmacists Fight Back Act to Crack Down on Predatory Drug Pricing. Rep Diana Harshbarger 11 Dec 2025.]